| 英文品名 |
ibritumomab tiuxetan |
| 名稱來源 |
p-INNList-81,1999;r-INNList-43,2000; |
| 化學(xué)表述 |
immunoglobulin G1, anti-(human CD20 (antigen)) (mouse monoclonal IDEC-Y2B8 γ1-chain), disulfide with mouse monoclonal IDEC-Y2B8 κ-chain, dimer, N-[2-[bis(carboxymethyl)amino]-3-(4-isothiocyanatophenyl)propyl]-N-[2-[bis(carboxymethyl)amino]propyl]glycine conjugate |
| CA登記號 |
206181-63-7 |
| 結(jié) 構(gòu) 式 |
 |
| 品種類別 |
免疫調(diào)節(jié)藥>單克隆抗體類 |
| 參考文獻(xiàn) |
MI(4903) |
|
